Sanara MedTech Files 8-K with Financials
Ticker: SMTI · Form: 8-K · Filed: Dec 4, 2024 · CIK: 714256
| Field | Detail |
|---|---|
| Company | Sanara Medtech Inc. (SMTI) |
| Form Type | 8-K |
| Filed Date | Dec 4, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financials, disclosure
TL;DR
Sanara MedTech dropped an 8-K on Dec 4th - check financials!
AI Summary
Sanara MedTech Inc. filed an 8-K on December 4, 2024, reporting information under Regulation FD and including financial statements and exhibits. The company, formerly known as Wound Management Technologies, Inc., is incorporated in Texas and its fiscal year ends on December 31st.
Why It Matters
This filing provides updated information and financial disclosures for Sanara MedTech Inc., which is important for investors to assess the company's current status and performance.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, typically containing standard disclosures and financial information, without immediate indications of significant new risks.
Key Players & Entities
- Sanara MedTech Inc. (company) — Registrant
- Wound Management Technologies, Inc. (company) — Former company name
- December 4, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What is Sanara MedTech Inc.'s state of incorporation?
Sanara MedTech Inc. is incorporated in Texas.
When does Sanara MedTech Inc.'s fiscal year end?
Sanara MedTech Inc.'s fiscal year ends on December 31st.
What was Sanara MedTech Inc. formerly known as?
Sanara MedTech Inc. was formerly known as Wound Management Technologies, Inc.
What is the SEC file number for Sanara MedTech Inc.?
The SEC file number for Sanara MedTech Inc. is 001-39678.
Filing Stats: 703 words · 3 min read · ~2 pages · Grade level 10.9 · Accepted 2024-12-04 07:30:55
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value SMTI The Nasdaq Capital
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex99-1.htm (EX-99.1) — 21KB
- ex99-1_001.jpg (GRAPHIC) — 465KB
- ex99-1_002.jpg (GRAPHIC) — 1743KB
- ex99-1_003.jpg (GRAPHIC) — 1100KB
- ex99-1_004.jpg (GRAPHIC) — 1089KB
- ex99-1_005.jpg (GRAPHIC) — 1348KB
- ex99-1_006.jpg (GRAPHIC) — 465KB
- ex99-1_007.jpg (GRAPHIC) — 813KB
- ex99-1_008.jpg (GRAPHIC) — 980KB
- ex99-1_009.jpg (GRAPHIC) — 1450KB
- ex99-1_010.jpg (GRAPHIC) — 762KB
- ex99-1_011.jpg (GRAPHIC) — 1335KB
- ex99-1_012.jpg (GRAPHIC) — 1107KB
- ex99-1_013.jpg (GRAPHIC) — 466KB
- ex99-1_014.jpg (GRAPHIC) — 1089KB
- ex99-1_015.jpg (GRAPHIC) — 668KB
- ex99-1_016.jpg (GRAPHIC) — 476KB
- ex99-1_017.jpg (GRAPHIC) — 890KB
- ex99-1_018.jpg (GRAPHIC) — 387KB
- ex99-1_019.jpg (GRAPHIC) — 381KB
- ex99-1_020.jpg (GRAPHIC) — 1345KB
- ex99-1_021.jpg (GRAPHIC) — 1177KB
- ex99-1_022.jpg (GRAPHIC) — 1119KB
- ex99-1_023.jpg (GRAPHIC) — 1931KB
- ex99-1_024.jpg (GRAPHIC) — 976KB
- 0001493152-24-048602.txt ( ) — 32640KB
- smti-20241204.xsd (EX-101.SCH) — 3KB
- smti-20241204_lab.xml (EX-101.LAB) — 33KB
- smti-20241204_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 4, 2024 Sanara MedTech Inc . By: /s/ Michael D. McNeil Name: Michael D. McNeil Title: Chief Financial Officer